Search

Your search keyword '"MONLUN, Marie"' showing total 48 results
Start Over Author "MONLUN, Marie"
48 results on '"MONLUN, Marie"'

5. Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518–2526

Author

Rigalleau, Vincent, primary, Larroumet, Alice, additional, Mohammedi, Kamel, additional, Baillet-Blanco, Laurence, additional, Monlun, Marie, additional, Delyfer, Marie-Noelle, additional, Korobelnik, Jean-François, additional, and Foussard, Ninon, additional

Published
2022
Full Text
View/download PDF

6. Comment on Sjöholm et al. Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-term Results From the Swedish Obese Subjects Study. Diabetes Care 2022;45:444–450

Author

Rigalleau, Vincent, primary, Barbet-Massin, Marie-Amélie, additional, Larroumet, Alice, additional, Mohammedi, Kamel, additional, Baillet-Blanco, Laurence, additional, Monlun, Marie, additional, Cherifi, Blandine, additional, and Foussard, Ninon, additional

Published
2022
Full Text
View/download PDF

9. Early Worsening of Diabetic Nephropathy in Type 2 Diabetes After Rapid Improvement in Chronic Severe Hyperglycemia

Author

Larroumet, Alice, MOLINA, Oceane, FOUSSARD, Ninon, MONLUN, Marie, BLANCO, Laurence, Mohammedi, Kamel, Rigalleau, Vincent, Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS), Bordeaux population health (BPH), and Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Published
2021

12. Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory

Author

Ducos, C., Rigo, M., LARROUMET, A., DELYFER, Marie-Noelle, KOROBELNIK, Jean-Francois, MONLUN, Marie, FOUSSARD, Ninon, Poupon, P., Haissaguerre, M., Blanco, L., Mohammedi, Kamel, Rigalleau, Vincent, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases, and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS)

Subjects
endocrine system diseases, Diabetes complications, Microangiopathy, Diabetic retinopathy, nutritional and metabolic diseases, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Skin autofluoresence, Advanced glycation end-products, Glycaemic memory
Abstract

AIMS: As diabetic retinopathy (DR) can occur even in well-controlled patients with type 2 diabetes (T2D), our study sought to determine whether it might be related to 'glucose memory' by evaluating patients' HbA1c over previous years and their skin autofluorescence (SAF). METHODS: In 334 patients with T2D and HbA1c levels≤8%, their available values of HbA1c from previous years were collected, and their SAF measured by an advanced glycation end-product (AGE) reader. Binary logistic regression analysis was then used to correlate DR with previously recorded HbA1c levels and to SAF, with adjustment for DR risk factors [age, gender, BMI, duration of diabetes, arterial hypertension, diabetic kidney disease (DKD), blood lipid levels and statin treatment]. RESULTS: Our patients were mostly men (58.4%) aged 63±10years, with a duration of diabetes of 13±10years and HbA1c=7.1±0.7%. Of these patients, 84 (25.1%) had DR, which was associated with longer duration of diabetes and greater prevalence of DKD. A total of 605 HbA1c values from previous years were collected for time periods -4±3 months (n=255), -16±4months (n=152), -30±4months (n=93) and -62±26 months (n=105). After adjustment, the association between DR and having an HbA1c higher than the median was significant only for the oldest previous HbA1c values: OR=6.75, 95% CI: 1.90-23.90. Moreover, SAF values were higher in those with DR [2.95±0.67 arbitrary units (AU)] vs 2.65±0.65 AU with no DR (P

Published
2021

14. Skin autofluorescence predicts cancer in subjects with type 2 diabetes

Author

Foussard, Ninon, primary, Larroumet, Alice, additional, Rigo, Marine, additional, Mohammedi, Kamel, additional, Baillet-Blanco, Laurence, additional, Poupon, Pauline, additional, Monlun, Marie, additional, Lecocq, Maxime, additional, Devouge, Anne-Claire, additional, Ducos, Claire, additional, Liebart, Marion, additional, Battaglini, Quentin, additional, and Rigalleau, Vincent, additional

Published
2021
Full Text
View/download PDF

16. Lung cancer and diabetes: A role for advanced glycation end-products?

Author

Rigalleau, Vincent, FOUSSARD, Ninon, BERTRAND, Alexia, MONLUN, Marie, BLANCO-BAILLET, Laurence, Mohammedi, Kamel, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases, and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS)

Subjects
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, ComputingMilieux_MISCELLANEOUS, LEHA
Abstract

International audience

Published
2020

20. Relationship between diabetic retinopathy stages and risk of major lower-extremity arterial disease in patients with type 2 diabetes

Author

Foussard, Ninon, primary, Saulnier, Pierre-Jean, primary, Potier, Louis, primary, Ragot, Stéphanie, primary, Schneider, Fabrice, primary, Gand, Elise, primary, Monlun, Marie, primary, Baillet-Blanco, Laurence, primary, Velho, Gilberto, primary, Marre, Michel, primary, Roussel, Ronan, primary, Rigalleau, Vincent, primary, Mohammedi, Kamel, primary, Hadjadj, Samy, primary, and Group, the SURDIAGENE Study, primary

Published
2020
Full Text
View/download PDF

22. Previous dramatic reduction of HbA1c and retinopathy in Type 2 Diabetes

Author

Larroumet, Alice, primary, Rigo, Marine, additional, Lecocq, Maxime, additional, Delyfer, Marie-Noelle, additional, Korobelnik, Jean-François, additional, Monlun, Marie, additional, Foussard, Ninon, additional, Poupon, Pauline, additional, Blanco, Laurence, additional, Mohammedi, Kamel, additional, and Rigalleau, Vincent, additional

Published
2020
Full Text
View/download PDF

27. Comment on Law et al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care 2019;42:810–815

Author

Foussard, Ninon, primary, Cambos, Sophie, additional, Poupon, Pauline, additional, Monlun, Marie, additional, Blanco, Laurence, additional, Haissaguerre, Magalie, additional, Grouthier, Virginie, additional, Velayoudom-Cephise, Fritz-Line, additional, Mohammedi, Kamel, additional, and Rigalleau, Vincent, additional

Published
2019
Full Text
View/download PDF

29. Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A1c Testing. Diabetes Care 2019;42:576–584

Author

Stankevich, Lioubov, primary, Galhaud, Jean-Philippe, additional, Kuvshinov, Roman, additional, Helmer, Catherine, additional, Poupon, Pauline, additional, Blanco, Laurence, additional, Monlun, Marie, additional, Foussard, Ninon, additional, Mohammedi, Kamel, additional, and Rigalleau, Vincent, additional

Published
2019
Full Text
View/download PDF

31. Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes.

Author

Foussard, Ninon, Saulnier, Pierre-Jean, Potier, Louis, Ragot, Stéphanie, Schneider, Fabrice, Gand, Elise, Monlun, Marie, Baillet-Blanco, Laurence, Velho, Gilberto, Marre, Michel, Roussel, Ronan, Rigalleau, Vincent, Mohammedi, Kamel, Hadjadj, Samy, and SURDIAGENE Study Group

Subjects
DIABETIC retinopathy, TYPE 2 diabetes, ARTERIAL diseases, SYSTOLIC blood pressure, DIABETIC nephropathies, GLYCOSYLATED hemoglobin, PERIPHERAL vascular disease diagnosis, LEG surgery, DISEASE progression, PREDICTIVE tests, PERIPHERAL vascular diseases, PROGNOSIS, DISEASE incidence, LEG, AMPUTATION, DIABETIC angiopathies, LONGITUDINAL method, DISEASE complications
Abstract

Objective: We evaluated the association between diabetic retinopathy stages and lower-extremity arterial disease (LEAD), its prognostic value, and the influence of potential contributors to this relationship in a prospective cohort of patients with type 2 diabetes.Research Design and Methods: Diabetic retinopathy was staged at baseline as absent, nonproliferative, or proliferative. A Cox regression model was fitted in order to compute the hazard ratio (HR) (95% CI) for major LEAD (lower-limb amputation or revascularization) during follow-up by baseline retinopathy stages. The retinopathy-LEAD association was assessed in subgroups by age, sex, diabetes duration, HbA1c, systolic blood pressure, diabetic kidney disease, smoking, and macrovascular disease at baseline. The performance of retinopathy in stratifying LEAD risk was assessed by using the C statistic, integrated discrimination improvement (IDI), and net reclassification improvement (NRI).Results: Among 1,320 participants without a history of LEAD at baseline, 94 (7.1%) developed a major LEAD during a 7.1-year median follow-up (incidence rate 9.6 per 1,000 person-years [95% CI 7.8-11.7]). The LEAD incidence rate (per 1,000 person-years) increased as retinopathy worsened: it was 5.5 (95% CI 3.9-7.8) in participants in whom retinopathy was absent, 14.6 (11.1-19.3) in those with nonproliferative retinopathy, and 20.1 (11.1-36.3) in those with proliferative retinopathy. Nonproliferative retinopathy (adjusted HR 2.31 [95% CI 1.43-3.81], P = 0.0006) and proliferative retinopathy (3.14 [1.40-6.15], P = 0.007) remained associated with major LEAD. No heterogeneity was observed across subgroups. Retinopathy enhanced the C statistic (+0.023 [95% CI 0.003-0.044], P = 0.02), IDI (0.209 [0.130-0.321], P < 0.001), and NRI (0.562 [0.382-0.799], P < 0.001) values for risk of LEAD, beyond traditional risk factors.Conclusions: An independent dose-response relationship was identified between diabetic retinopathy stages and major LEAD. Retinopathy yielded incremental prognostic information for stratifying risk of LEAD, suggesting its usefulness as a predictor of LEAD. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

35. Comment on Gordin et al. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 2018;41:815–822

Author

Azar, Marie, primary, Coirier, Elise, additional, Delyfer, Marie-Noelle, additional, Korobelnik, Jean-François, additional, Mohammedi, Kamel, additional, Blanco, Laurence, additional, Alexandre, Laure, additional, Monlun, Marie, additional, and Rigalleau, Vincent, additional

Published
2018
Full Text
View/download PDF

39. Lung cancer and diabetes: A role for advanced glycation end‐products?

Author

Rigalleau, Vincent, Foussard, Ninon, Bertrand, Alexia, Monlun, Marie, Blanco, Laurence, and Mohammedi, Kamel

Subjects
ADVANCED glycation end-products, LUNG cancer, TYPE 2 diabetes, DIABETES
Abstract

Dear sir, We were interested by the article from Yi et al on the association between diabetes and lung cancer.1 Although the relation was significant only for women, the studies included in the meta-analysis were heterogenous and significance was obtained in some subgroups, like overweighted subjects. Ten from the twelve subjects who developed a lung cancer had a previous skin autofluorescence higher than the median 2.60 AU value ( I P i = .032). Their accumulation in the skin of subjects with diabetes who developed a lung cancer, as we found, is probably not innocent. [Extracted from the article]

Published
2021
Full Text
View/download PDF

44. Comment on Evron et al. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A1c Testing. Diabetes Care 2019;42:576-584.

Author

Stankevich, Lioubov, Galhaud, Jean-Philippe, Kuvshinov, Roman, Helmer, Catherine, Poupon, Pauline, Blanco, Laurence, Monlun, Marie, Foussard, Ninon, Mohammedi, Kamel, and Rigalleau, Vincent

Subjects
PREDIABETIC state, DIABETES, HEMOGLOBINS
Abstract

The authors comment on the study by Evron et al that evaluated the rate of use of HBA1c test as screening for prediabetes and diabetes done by the Labexa clinical laboratory group in New Aquitaine, France. They note that expanding use of HBA1c for screening diabetes led to 25% diagnosis of the condition. However, screening 21,102 people in a population of 6 million is not considered sufficient action for public health.

Published
2019
Full Text
View/download PDF

45. Comment on Pongrac Barlovic et al. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up. Diabetes Care 2018;41:2487-2494.

Author

Camoin, Marion, Delyfer, Marie-Noelle, Korobelnik, Jean-François, Mohammedi, Kamel, Blanco, Laurence, Foussard, Ninon, Poupon, Pauline, Monlun, Marie, Haissaguerre, Magalie, and Rigalleau, Vincent

Subjects
TYPE 1 diabetes, RETROLENTAL fibroplasia, DIABETIC retinopathy, DIABETES, DIABETIC nephropathies
Abstract

The article comments on a study related to the association of severe diabetic retinopathy (SDR) with cardiovascular outcomes in long-standing type 1 diabetes. It notes that SDR predisposes to foot ulcers and amputations in type 1 diabetes, it is suggested that this association may be mediated by more diabetic peripheral neuropathy.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results